These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8576916)

  • 1. Structure-activity relationships of the quinolone antibacterials against mycobacteria: effect of structural changes at N-1 and C-7.
    Renau TE; Sanchez JP; Gage JW; Dever JA; Shapiro MA; Gracheck SJ; Domagala JM
    J Med Chem; 1996 Feb; 39(3):729-35. PubMed ID: 8576916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and antibacterial activity of quinolone-based compounds containing a coumarin moiety.
    Emami S; Foroumadi A; Faramarzi MA; Samadi N
    Arch Pharm (Weinheim); 2008 Jan; 341(1):42-8. PubMed ID: 18072241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationships of quinolone agents against mycobacteria: effect of structural modifications at the 8 position.
    Renau TE; Gage JW; Dever JA; Roland GE; Joannides ET; Shapiro MA; Sanchez JP; Gracheck SJ; Domagala JM; Jacobs MR; Reynolds RC
    Antimicrob Agents Chemother; 1996 Oct; 40(10):2363-8. PubMed ID: 8891145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between the structure and antimycobacterial activity of substituted salicylanilides.
    Waisser K; Bures O; Holý P; Kunes J; Oswald R; Jirásková L; Pour M; Klimesová V; Kubicová L; Kaustová J
    Arch Pharm (Weinheim); 2003 Mar; 336(1):53-71. PubMed ID: 12666254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent 6-desfluoro-8-methylquinolones as new lead compounds in antibacterial chemotherapy.
    Cecchetti V; Fravolini A; Palumbo M; Sissi C; Tabarrini O; Terni P; Xin T
    J Med Chem; 1996 Dec; 39(25):4952-7. PubMed ID: 8960555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative structure-activity relationships for the in vitro antimycobacterial activity of pyrazinoic acid esters.
    Bergmann KE; Cynamon MH; Welch JT
    J Med Chem; 1996 Aug; 39(17):3394-400. PubMed ID: 8765523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In-vitro activity of two hybrid synthetic peptides having antimicrobial activity against mycobacteria].
    Zerbini E; Andreu D; Tonarelli G; Sequeira MD
    Rev Argent Microbiol; 2006; 38(4):221-3. PubMed ID: 17370578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative structure-activity relationship (QSAR) studies of quinolone antibacterials against M. fortuitum and M. smegmatis using theoretical molecular descriptors.
    Bagchi MC; Mills D; Basak SC
    J Mol Model; 2007 Jan; 13(1):111-20. PubMed ID: 16932890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimycobacterial terpenoids from Juniperus communis L. (Cuppressaceae).
    Gordien AY; Gray AI; Franzblau SG; Seidel V
    J Ethnopharmacol; 2009 Dec; 126(3):500-5. PubMed ID: 19755141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and ex vivo activity of new derivatives of acetohydroxyacid synthase inhibitors against Mycobacterium tuberculosis and non-tuberculous mycobacteria.
    Sohn H; Lee KS; Ko YK; Ryu JW; Woo JC; Koo DW; Shin SJ; Ahn SJ; Shin AR; Song CH; Jo EK; Park JK; Kim HJ
    Int J Antimicrob Agents; 2008 Jun; 31(6):567-71. PubMed ID: 18337064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antibacterial activity of new fluoroquinolones containing a substituted N-(phenethyl)piperazine moiety.
    Foroumadi A; Ghodsi S; Emami S; Najjari S; Samadi N; Faramarzi MA; Beikmohammadi L; Shirazi FH; Shafiee A
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3499-503. PubMed ID: 16644219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformationally constrained analogs of N-substituted piperazinylquinolones: synthesis and antibacterial activity of N-(2,3-dihydro-4-hydroxyimino-4H-1-benzopyran-3-yl)-piperazinylquinolones.
    Emami S; Foroumadi A; Samadi N; Faramarzi MA; Rajabalian S
    Arch Pharm (Weinheim); 2009 Jul; 342(7):405-11. PubMed ID: 19544301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of lipophilicity at N-1 on activity of fluoroquinolones against mycobacteria.
    Renau TE; Sanchez JP; Shapiro MA; Dever JA; Gracheck SJ; Domagala JM
    J Med Chem; 1995 Jul; 38(15):2974-7. PubMed ID: 7636859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel fluoroquinolone antibacterial agents containing oxime-substituted (aminomethyl)pyrrolidines: synthesis and antibacterial activity of 7-(4-(aminomethyl)-3-(methoxyimino)pyrrolidin-1-yl)-1-cyclopropyl-6- fluoro-4-oxo-1,4-dihydro[1,8]naphthyridine-3-carboxylic acid (LB20304).
    Hong CY; Kim YK; Chang JH; Kim SH; Choi H; Nam DH; Kim YZ; Kwak JH
    J Med Chem; 1997 Oct; 40(22):3584-93. PubMed ID: 9357525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of extracts and constituents of Pelagonium against rapidly growing mycobacteria.
    Seidel V; Taylor PW
    Int J Antimicrob Agents; 2004 Jun; 23(6):613-9. PubMed ID: 15194133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antimycobacterial activity of pyridylmethylsulfanyl and naphthylmethylsulfanyl derivatives of benzazoles, 1, 2, 4-triazole, and pyridine-2-carbothioamide/-2-carbonitrile.
    Zahajská L; Klimesová V; Kocí J; Waisser K; Kaustová J
    Arch Pharm (Weinheim); 2004 Oct; 337(10):549-55. PubMed ID: 15476287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel antibacterial 8-chloroquinolone with a distorted orientation of the N1-(5-amino-2,4-difluorophenyl) group.
    Kuramoto Y; Ohshita Y; Yoshida J; Yazaki A; Shiro M; Koike T
    J Med Chem; 2003 May; 46(10):1905-17. PubMed ID: 12723953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibacterial activity of long-chain fatty alcohols against mycobacteria.
    Mukherjee K; Tribedi P; Mukhopadhyay B; Sil AK
    FEMS Microbiol Lett; 2013 Jan; 338(2):177-83. PubMed ID: 23136919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and antibacterial evaluation of 1beta-methyl-2-[5-(1-methoxyimino-2-substituted sulfonamide ethyl)pyrrolidin-3-ylthio]carbapenems and their related compounds.
    Jeon H; Jo NH; Yoo KH; Choi JH; Cho H; Cho JH; Oh CH
    Eur J Med Chem; 2007 Mar; 42(3):358-64. PubMed ID: 17156896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimycobacterial activity of 3'- and 4'-fluorothiobenzanilides.
    Waisser K; Kunes J; Odlerová Z; Roman M; Kubicová L; Horák V
    Pharmazie; 1998 Mar; 53(3):193-5. PubMed ID: 9547521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.